BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 38374020)

  • 1. Construction of a TF-miRNA-mRNA Regulatory Network for Diabetic Nephropathy.
    Dong F; Zheng L; Yang G
    Arch Esp Urol; 2024 Jan; 77(1):104-112. PubMed ID: 38374020
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identifying C1QB, ITGAM, and ITGB2 as potential diagnostic candidate genes for diabetic nephropathy using bioinformatics analysis.
    Hu Y; Yu Y; Dong H; Jiang W
    PeerJ; 2023; 11():e15437. PubMed ID: 37250717
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bioinformatics Analysis of the Mechanisms of Diabetic Nephropathy
    Guo M; Dai Y; Jiang L; Gao J
    Front Endocrinol (Lausanne); 2022; 13():934022. PubMed ID: 35909518
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Integrative analyses of biomarkers and pathways for diabetic nephropathy.
    Li B; Zhao X; Xie W; Hong Z; Zhang Y
    Front Genet; 2023; 14():1128136. PubMed ID: 37113991
    [No Abstract]   [Full Text] [Related]  

  • 5. Investigation of mechanisms of mesenchymal stem cells for treatment of diabetic nephropathy via construction of a miRNA-TF-mRNA network.
    Yang H; Zhang X; Xin G
    Ren Fail; 2018 Nov; 40(1):136-145. PubMed ID: 29532746
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of Serum Exosome-Derived circRNA-miRNA-TF-mRNA Regulatory Network in Postmenopausal Osteoporosis Using Bioinformatics Analysis and Validation in Peripheral Blood-Derived Mononuclear Cells.
    Dong Q; Han Z; Tian L
    Front Endocrinol (Lausanne); 2022; 13():899503. PubMed ID: 35757392
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of microRNA-mRNA-TF regulatory networks in periodontitis by bioinformatics analysis.
    Gao X; Zhao D; Han J; Zhang Z; Wang Z
    BMC Oral Health; 2022 Apr; 22(1):118. PubMed ID: 35397550
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Identification of co-expressed central genes and transcription factors in acute myocardial infarction and diabetic nephropathy.
    Li B; Zhao X; Xie W; Hong Z; Cao Y; Zhang Y; Ding Y
    BMC Med Genomics; 2024 May; 17(1):134. PubMed ID: 38764052
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Construction and analysis of mRNA, miRNA, lncRNA, and TF regulatory networks reveal the key genes associated with prostate cancer.
    Ye Y; Li SL; Wang SY
    PLoS One; 2018; 13(8):e0198055. PubMed ID: 30138363
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction and Bioinformatics Analysis of the miRNA-mRNA Regulatory Network in Diabetic Nephropathy.
    Li Y; Xu Y; Hou Y; Li R
    J Healthc Eng; 2021; 2021():8161701. PubMed ID: 34840704
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Key Genes and Signaling Pathways Contribute to the Pathogensis of Diabetic Nephropathy.
    Yang H; Lian D; Zhang X; Li H; Xin G
    Iran J Kidney Dis; 2019 Mar; 13(2):87-97. PubMed ID: 30988245
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Construction of a TFs-miRNA-mRNA network related to idiopathic pulmonary fibrosis.
    Su M; Liu J; Wu X; Chen X; Xiao Q; Jiang N
    Ann Transl Med; 2023 Jan; 11(2):78. PubMed ID: 36819574
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Crucial genes associated with diabetic nephropathy explored by microarray analysis.
    Wang Z; Wang Z; Zhou Z; Ren Y
    BMC Nephrol; 2016 Sep; 17(1):128. PubMed ID: 27613243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Seven basement membrane-specific expressed genes are considered potential biomarkers for the diagnosis and treatment of diabetic nephropathy.
    Gui H; Chen X; Ye L; Ma H
    Acta Diabetol; 2023 Apr; 60(4):493-505. PubMed ID: 36627452
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Network pharmacology-based identification of miRNA expression of Astragalus membranaceus in the treatment of diabetic nephropathy.
    Dai Y; Guo M; Jiang L; Gao J
    Medicine (Baltimore); 2022 Feb; 101(5):e28747. PubMed ID: 35119030
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Integrated Bioinformatics and Clinical Correlation Analysis of Key Genes, Pathways, and Potential Therapeutic Agents Related to Diabetic Nephropathy.
    Chen S; Chen L; Jiang H
    Dis Markers; 2022; 2022():9204201. PubMed ID: 35637650
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of key genes and biological regulatory mechanisms in diabetic nephropathy: Meta-analysis of gene expression datasets.
    Hojjati F; Roointan A; Gholaminejad A; Eshraghi Y; Gheisari Y
    Nefrologia (Engl Ed); 2023; 43(5):575-586. PubMed ID: 36681521
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comprehensive analysis of diabetic nephropathy expression profile based on weighted gene co-expression network analysis algorithm.
    Gholaminejad A; Fathalipour M; Roointan A
    BMC Nephrol; 2021 Jul; 22(1):245. PubMed ID: 34215202
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Identification of tubulointerstitial genes and ceRNA networks involved in diabetic nephropathy via integrated bioinformatics approaches.
    Cao H; Rao X; Jia J; Yan T; Li D
    Hereditas; 2022 Sep; 159(1):36. PubMed ID: 36154667
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of biological targets of therapeutic intervention for diabetic nephropathy with bioinformatics approach.
    Wu T; Li Q; Wu T; Liu HY
    Exp Clin Endocrinol Diabetes; 2014 Nov; 122(10):587-91. PubMed ID: 25003364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.